|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0013216,
umls-concept:C0019829,
umls-concept:C0030705,
umls-concept:C0332293,
umls-concept:C0936012,
umls-concept:C1257890,
umls-concept:C1274040,
umls-concept:C1522449,
umls-concept:C1556085,
umls-concept:C1707455,
umls-concept:C2603343
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-2-7
|
|
pubmed:abstractText |
The optimal treatment of elderly patients with Hodgkin's lymphoma (HL) is still a matter of debate. Since many of these patients receive combined modality treatment, we evaluated the impact of different radiation field sizes, that is extended-field (EF) or involved-field (IF) technique when given after four cycles of chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:BoissevainFF,
pubmed-author:DühmkeEE,
pubmed-author:DiehlVV,
pubmed-author:EleyJ DJD,
pubmed-author:EngertAA,
pubmed-author:German Hodgkin Study Group,
pubmed-author:HaverkampHH,
pubmed-author:KlimpAA,
pubmed-author:KochPP,
pubmed-author:LohriAA,
pubmed-author:Müller-HermelinkKK,
pubmed-author:MüllerR PRP,
pubmed-author:PfistnerBB,
pubmed-author:TrentMM,
pubmed-author:WorstPP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
357-63
|
|
pubmed:meshHeading |
pubmed-meshheading:17071932-Adolescent,
pubmed-meshheading:17071932-Adult,
pubmed-meshheading:17071932-Aged,
pubmed-meshheading:17071932-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17071932-Bleomycin,
pubmed-meshheading:17071932-Combined Modality Therapy,
pubmed-meshheading:17071932-Cyclophosphamide,
pubmed-meshheading:17071932-Dacarbazine,
pubmed-meshheading:17071932-Disease Progression,
pubmed-meshheading:17071932-Doxorubicin,
pubmed-meshheading:17071932-Female,
pubmed-meshheading:17071932-Germany,
pubmed-meshheading:17071932-Hodgkin Disease,
pubmed-meshheading:17071932-Humans,
pubmed-meshheading:17071932-Male,
pubmed-meshheading:17071932-Middle Aged,
pubmed-meshheading:17071932-Neoplasm Staging,
pubmed-meshheading:17071932-Prednisone,
pubmed-meshheading:17071932-Procarbazine,
pubmed-meshheading:17071932-Prognosis,
pubmed-meshheading:17071932-Radiation Injuries,
pubmed-meshheading:17071932-Survival Rate,
pubmed-meshheading:17071932-Treatment Outcome,
pubmed-meshheading:17071932-Vinblastine,
pubmed-meshheading:17071932-Vincristine
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group.
|
|
pubmed:affiliation |
Department I of Internal Medicine, University Hospital Cologne, Germany. beate.klimm@uk-koeln.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
